CStone receives CTA approval in China to start Phase I trial for FGFR4 inhibitor BLU-554 (CS3008)
SUZHOU, China, Jan. 29, 2019 /…
Apollo Hospitals Opens South East Asia’s First Proton Therapy Centre for Cancer
CHENNAI, India, Jan. 25, 2019 …
deCODE Publishes the First Full Resolution Genetic Map of the Human Genome
REYKJAVIK, Iceland, Jan. 25, 2…
Merck Grants Exclusive License to Vertex for Two DNA Damage Response Inhibitors
DARMSTADT, Germany, Jan. 24, 2…
I-Mab Biopharma Receives U.S. FDA IND Clearance for Proprietary CD73 Antibody TJD5
SHANGHAI, Jan. 22, 2019 /PRNew…
